Hypertension and Atrial Fibrillation: A Conundrum?

Atrial fibrillation is an important cause of preventable thromboembolic stroke. In this webinar, Professor Thomas Unger (Maastricht University, the Netherlands) discusses the pathogenesis of atrial fibrillation and the role of the renin-angiotensin system. He then shared clinical evidence on the benefits of anticoagulation on the prevention of thromboembolic stroke in atrial fibrillation, as well as the evidence base supporting non-vitamin K oral anticoagulants. Lastly, he discussed specific clinical aspects on the use of dabigatran as the first non-vitamin K oral anticoagulant for stroke prevention in atrial fibrillation.

Estimated time of Completion: 22 mins.

CPD Points: 1 Point

PRC Program No: PROG-2023-59765